PROTECT-trial Consortium (@PROTECT_trial) header
PROTECT-trial Consortium (@PROTECT_trial) profile picture

The PROTECT-trial Consortium will conduct the phase three clinical trial: PROtons vs Photon Therapy for Esophageal Cancer- a Trimodality strategy.

Joined February 2021
Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)Photo by PROTECT-trial Consortium (@PROTECT_trial)
Presentation, by Lone Hoffmann in #ESTRO2021. OC-0631 - Proton and photon treatment planning comparison for oesophageal cancer between six European centres. #aeprot #protontherapy #particletherapy #protonterapia #oesophagealcancer @PROTECT_trial
3
2
PROTECT-trial Consortium retweeted
Lone Hoffmann presents (some of) the extensive pre-trial RTQA work for @PROTECT_trial. Getting 8 international proton centres to produce comparable & robust PT (and XRT!) plans is not straightforward. And, perhaps counterintuitively, XRT plans are overall less robust #ESTRO2021
2
4
17